177 related articles for article (PubMed ID: 27525648)
21. Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury.
Higashijima Y; Tanaka T; Yamaguchi J; Tanaka S; Nangaku M
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F878-87. PubMed ID: 25656369
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.
Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611
[TBL] [Abstract][Full Text] [Related]
23. DPP-4 Inhibition with Anagliptin Reduces Lipotoxicity-Induced Insulin Resistance and Steatohepatitis in Male Mice.
Sakai Y; Chen G; Ni Y; Zhuge F; Xu L; Nagata N; Kaneko S; Ota T; Nagashimada M
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32790863
[TBL] [Abstract][Full Text] [Related]
24. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
Moritoh Y; Takeuchi K; Hazama M
J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
[TBL] [Abstract][Full Text] [Related]
25. Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice.
Iwamoto Y; Kimura T; Dan K; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nogami Y; Shirakiya Y; Nakanishi S; Mune T; Kaku K; Kaneto H
Diabetes Obes Metab; 2024 Jun; 26(6):2339-2348. PubMed ID: 38504118
[TBL] [Abstract][Full Text] [Related]
26. Assisted Reproductive Technologies Predispose to Insulin Resistance and Obesity in Male Mice Challenged With a High-Fat Diet.
Cerny D; Sartori C; Rimoldi SF; Meister T; Soria R; Bouillet E; Scherrer U; Rexhaj E
Endocrinology; 2017 May; 158(5):1152-1159. PubMed ID: 28323978
[TBL] [Abstract][Full Text] [Related]
27. Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model.
Plante GE; Perreault M; Lanthier A; Marette A; Maheux P
Cardiovasc Res; 2003 Oct; 59(4):963-70. PubMed ID: 14553836
[TBL] [Abstract][Full Text] [Related]
28. Insulin receptor substrate-2 (Irs2) in endothelial cells plays a crucial role in insulin secretion.
Hashimoto S; Kubota N; Sato H; Sasaki M; Takamoto I; Kubota T; Nakaya K; Noda M; Ueki K; Kadowaki T
Diabetes; 2015 Mar; 64(3):876-86. PubMed ID: 25277391
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo.
Kim SH; Jung E; Yoon MK; Kwon OH; Hwang DM; Kim DW; Kim J; Lee SM; Yim HJ
Eur J Pharmacol; 2016 Oct; 788():54-64. PubMed ID: 27298192
[TBL] [Abstract][Full Text] [Related]
30. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
31. Hibiscus sabdariffa polyphenols prevent palmitate-induced renal epithelial mesenchymal transition by alleviating dipeptidyl peptidase-4-mediated insulin resistance.
Huang CN; Wang CJ; Yang YS; Lin CL; Peng CH
Food Funct; 2016 Jan; 7(1):475-82. PubMed ID: 26514092
[TBL] [Abstract][Full Text] [Related]
32. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
33. Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats.
Ross RM; Wadley GD; Clark MG; Rattigan S; McConell GK
Diabetes; 2007 Dec; 56(12):2885-92. PubMed ID: 17881613
[TBL] [Abstract][Full Text] [Related]
34. Anagliptin, a dipeptidyl peptidase-4 inhibitor, improved bladder function and hemodynamics in rats with bilateral internal iliac artery ligation.
Hotta Y; Takahashi S; Tokoro M; Naiki-Ito A; Maeda K; Kawata R; Kataoka T; Ohta Y; Hamakawa T; Takahashi S; Yasui T; Kimura K
Neurourol Urodyn; 2020 Sep; 39(7):1922-1929. PubMed ID: 32725853
[TBL] [Abstract][Full Text] [Related]
35. Endothelial TFEB (Transcription Factor EB) Improves Glucose Tolerance via Upregulation of IRS (Insulin Receptor Substrate) 1 and IRS2.
Sun J; Lu H; Liang W; Zhao G; Ren L; Hu D; Chang Z; Liu Y; Garcia-Barrio MT; Zhang J; Chen YE; Fan Y
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):783-795. PubMed ID: 33297755
[TBL] [Abstract][Full Text] [Related]
36. Dipeptidyl peptidase-4 inhibition in diabetic rats leads to activation of the transcription factor CREB in β-cells.
Pugazhenthi S; Qin L; Bouchard R
Eur J Pharmacol; 2015 May; 755():42-9. PubMed ID: 25720341
[TBL] [Abstract][Full Text] [Related]
37. Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
Giannocco G; Oliveira KC; Crajoinas RO; Venturini G; Salles TA; Fonseca-Alaniz MH; Maciel RM; Girardi AC
Eur J Pharmacol; 2013 Jan; 698(1-3):74-86. PubMed ID: 23051671
[TBL] [Abstract][Full Text] [Related]
38. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.
Erdogdu O; Nathanson D; Sjöholm A; Nyström T; Zhang Q
Mol Cell Endocrinol; 2010 Aug; 325(1-2):26-35. PubMed ID: 20452396
[TBL] [Abstract][Full Text] [Related]
39. DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells.
Ma Y; Wang J; Wang C; Zhang Q; Xu Y; Liu H; Xiang X; Ma J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3823-3831. PubMed ID: 31556325
[TBL] [Abstract][Full Text] [Related]
40. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
